Alector, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ALEC, updated each market day.
ALEC AI Sentiment
AI sees no strong directional signal for Alector, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Alector, Inc. Common Stock
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Sector
Exchange
Market Cap
$206,565,300
Cap Tier
Employees
103
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
Feb. 7, 2019
Website
ALEC Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ALEC Volatility
Alector, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
